Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mesa Laboratories (MLAB) Payables (2016 - 2025)

Mesa Laboratories' Payables history spans 15 years, with the latest figure at $5.3 million for Q4 2025.

  • On a quarterly basis, Payables fell 8.6% to $5.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $5.3 million, a 8.6% decrease, with the full-year FY2025 number at $5.7 million, down 4.87% from a year prior.
  • Payables hit $5.3 million in Q4 2025 for Mesa Laboratories, up from $5.1 million in the prior quarter.
  • Over the last five years, Payables for MLAB hit a ceiling of $7.9 million in Q1 2022 and a floor of $4.0 million in Q2 2021.
  • Historically, Payables has averaged $5.9 million across 5 years, with a median of $5.7 million in 2024.
  • Biggest five-year swings in Payables: soared 140.98% in 2021 and later plummeted 37.84% in 2023.
  • Tracing MLAB's Payables over 5 years: stood at $7.8 million in 2021, then dropped by 19.66% to $6.3 million in 2022, then fell by 27.58% to $4.6 million in 2023, then rose by 26.2% to $5.7 million in 2024, then fell by 8.6% to $5.3 million in 2025.
  • Business Quant data shows Payables for MLAB at $5.3 million in Q4 2025, $5.1 million in Q3 2025, and $6.3 million in Q2 2025.